This brand name is authorized in Nigeria.
The drug PIPART contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
6A9O50735X - ARTENIMOL
|
|
Artemisinin is used in the treatment of malaria due to species Plasmodium. |
|
2
|
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-4503 | Tablet | PIPART TABLET TAB 40 mg; 320 mg 1 X 9 | 26 RNW-PP-261373 PIPART TABLET DIHYDROARTEMISININ 40MG AND PIPERAQUINE PHOSPHATE 320MG EACH TABLET CONTAINS DIHYDOARTEMISININ 40MG AND PIPERAQUINE PHOSPHATE 320MG EXCIPIENTS Pre-gelatinised starch Dextrin Hypromellose (E464) Croscarmellose sodium Magnesium stearate (E572) A4-4503 Drugs Imported Products 1X9 OTC 4/26/2022 DIGITALL HEALTHCARE LTD, 300A, RAFIU BABATUNDE ROAD, APPLY JUNCTION 80638003398 emekakuchu@yahoo.com GLOBELA PHARM PVT. LTD 394230, 357, G.I.D.C SACHIN SURAT-394230, GUJARAT, INDIA, India | 31/10/2023 |
| B4-7020 | Powder for suspension | PIPART POWDER FOR ORAL SUSPENSION 80mg/640mg PWD_F_SOL 80 mg/80 mL; 640 mg/80 mL 1x80ml | 63 RNW-PP-261381 PIPART POWDER FOR ORAL SUSPENSION 80mg/640mg DIHYDROARTEMISININ 80MG AND PIPERAQUINE PHOSPHATE 640MG EACH 80ML CONTAINS DIHYDOARTEMISININ 80MG AND PIPERAQUINE PHOSPHATE 640MG/80ML EXCIPIENTS Pre-gelatinised starch Dextrin Hypromellose (E464) Croscarmellose sodium Magnesium stearate (E572) B4-7020 Drugs Imported Products 1x80ml Over The Counter (OTC) 4/26/2022 DIGITALL HEALTHCARE LTD, Plot 3155, Block 68 Olympic Street, Amuwo-Odofin, Lagos State. 80638003398 emekakuchu@yahoo.com GLOBELA PHARMA. PVT LTD., 357 G.I.D.C SACHIN SURAT 394 230. GUJARAT INDIA, India | 30/11/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| P01BF05 | Artenimol and piperaquine | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-4503, B4-7020 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.